PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Sanggenol L

Inquiry

Cat. No.: X22-05-ZQ423

Sanggenol L

Synonym: 329319-20-2; Sanggenol L; 2-(2,4-Dihydroxyphenyl)-5-Hydroxy-8-methyl-8-(4-methylpent-3-enyl)-2,3-dihydropyrano[2,3-h]chromen-4-one

CAS Number: 329319-20-2
Compound CID: 11796489

Product Size

5 mg; 20 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

Sanggenol L induces caspase-dependent and caspase-independent apoptosis in melanoma skin cancer cells. Sanggenol L induces apoptosis via suppression of PI3K/Akt/mTOR signaling and cell cycle arrest via activation of p53. This product can be used for research in the functional product, pharmaceutical, and personal care product industries.

Molecular Weight

424.493

Molecular Formula

C₂₅H₂₈O₆

Form

Powder

Purity

≥98%, determined by HPLC.

Identity

Confirmed by MS and NMR.

Applications

Sanggenol L can be used for research in the functional product, pharmaceutical, and personal care product industries.

Safety Information

Personal Protective Equipment

Gloves, eyeshields, N95 mask

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.